| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | N Bardeesy | |
| A F Hezel | |||
| P2860 | cites work | Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome | Q42977726 |
| Prevention of pancreatic cancer induction in hamsters by metformin | Q43552285 | ||
| Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells. | Q46890287 | ||
| The Drosophila Lkb1 kinase is required for spindle formation and asymmetric neuroblast division | Q47071561 | ||
| Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas. | Q51716801 | ||
| Genome-wide survey of protein kinases required for cell cycle progression. | Q52654188 | ||
| Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer. | Q53342336 | ||
| Allelic imbalance at the LKB1 (STK11) locus in tumours from patients with Peutz-Jeghers' syndrome provides evidence for a hamartoma-(adenoma)-carcinoma sequence. | Q54190005 | ||
| Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis. | Q54322682 | ||
| Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. | Q54462818 | ||
| Generalized Intestinal Polyposis and Melanin Spots of the Oral Mucosa, Lips and Digits | Q57073474 | ||
| Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome | Q57240072 | ||
| Identification of genes required for cytoplasmic localization in early C. elegans embryos | Q68273724 | ||
| Feminizing Sertoli cell tumors in boys with Peutz-Jeghers syndrome | Q72361770 | ||
| Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms | Q73670302 | ||
| LKB1 protein expression in neuroendocrine tumors of the lung | Q80501532 | ||
| Accelerated onsets of gastric hamartomas and hepatic adenomas/carcinomas in Lkb1+/-p53-/- compound mutant mice | Q81461035 | ||
| Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade | Q21245891 | ||
| Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling | Q24296680 | ||
| Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD | Q24305094 | ||
| LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1 | Q24310603 | ||
| MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption | Q24313701 | ||
| LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis | Q24319729 | ||
| AMPK phosphorylation of raptor mediates a metabolic checkpoint | Q24329244 | ||
| LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo | Q24531930 | ||
| The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress | Q24633606 | ||
| LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome | Q24655120 | ||
| Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers | Q24671334 | ||
| Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3 | Q24672153 | ||
| STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas | Q24685646 | ||
| Peutz-Jeghers syndrome with ovarian sex cord tumor with annular tubules and cervical adenoma malignum | Q37375962 | ||
| Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice | Q39995270 | ||
| The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity | Q40017323 | ||
| Energy-dependent regulation of cell structure by AMP-activated protein kinase | Q40135869 | ||
| LKB1/STRAD promotes axon initiation during neuronal polarization. | Q40136806 | ||
| Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells | Q40216291 | ||
| Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome | Q41022988 | ||
| Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms | Q41982039 | ||
| AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase | Q42165233 | ||
| Reactive nitrogen species induced by hyperglycemia suppresses Akt signaling and triggers apoptosis by upregulating phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) in an LKB1-dependent manner | Q42518946 | ||
| LKB1 regulates neuronal migration and neuronal differentiation in the developing neocortex through centrosomal positioning. | Q42520723 | ||
| LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis | Q42547962 | ||
| Inhibition of germline proliferation during C. elegans dauer development requires PTEN, LKB1 and AMPK signalling | Q42677856 | ||
| Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis. | Q42844340 | ||
| Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes | Q42850964 | ||
| Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling | Q27851424 | ||
| A serine/threonine kinase gene defective in Peutz-Jeghers syndrome | Q28119198 | ||
| Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma | Q28141888 | ||
| Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1 | Q28189311 | ||
| Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth | Q28211693 | ||
| The AMP-activated protein kinase cascade--a unifying system for energy control | Q28239257 | ||
| LKB1 tumor suppressor protein: PARtaker in cell polarity | Q28265461 | ||
| The LKB1 tumor suppressor negatively regulates mTOR signaling | Q28272728 | ||
| The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector | Q28285140 | ||
| Analysis of the LKB1-STRAD-MO25 complex | Q28294900 | ||
| Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis | Q28300857 | ||
| Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366 | Q28504452 | ||
| The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin | Q28590162 | ||
| LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons | Q28591764 | ||
| Lkb1 deficiency causes prostate neoplasia in the mouse | Q28592491 | ||
| Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice | Q28594689 | ||
| Metformin and reduced risk of cancer in diabetic patients | Q29616275 | ||
| AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy | Q29618101 | ||
| AMP-activated protein kinase induces a p53-dependent metabolic checkpoint | Q29618123 | ||
| TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia | Q29618875 | ||
| The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis | Q29622875 | ||
| LKB1 modulates lung cancer differentiation and metastasis | Q30080027 | ||
| Par1b promotes hepatic-type lumen polarity in Madin Darby canine kidney cells via myosin II- and E-cadherin-dependent signaling | Q30444602 | ||
| Peutz-Jeghers syndrome: 78-year follow-up of the original family | Q33601730 | ||
| Peutz-Jeghers syndrome | Q33679883 | ||
| Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction | Q33841869 | ||
| Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis | Q34066238 | ||
| Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis | Q34156001 | ||
| Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas | Q34503041 | ||
| Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest | Q34504424 | ||
| Very high risk of cancer in familial Peutz-Jeghers syndrome | Q34512286 | ||
| Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma | Q34515560 | ||
| Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1). | Q34523729 | ||
| Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome | Q34526950 | ||
| Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation | Q34527075 | ||
| A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity | Q34530696 | ||
| Cancer and the Peutz-Jeghers syndrome | Q34532616 | ||
| Interaction of activator of G-protein signaling 3 (AGS3) with LKB1, a serine/threonine kinase involved in cell polarity and cell cycle progression: phosphorylation of the G-protein regulatory (GPR) motif as a regulatory mechanism for the interaction | Q34533191 | ||
| LKB1-dependent signaling pathways | Q34535140 | ||
| LKB1 (XEEK1) regulates Wnt signalling in vertebrate development | Q34536922 | ||
| Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. | Q34546258 | ||
| Relative frequency and morphology of cancers in STK11 mutation carriers | Q34548485 | ||
| Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2. | Q34551816 | ||
| Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity. | Q34556342 | ||
| LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes | Q34558919 | ||
| High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome | Q34562591 | ||
| Peutz-Jeghers syndrome and management recommendations | Q34566543 | ||
| Frequency and spectrum of cancers in the Peutz-Jeghers syndrome | Q34567595 | ||
| Increased risk of cancer in the Peutz-Jeghers syndrome | Q34690977 | ||
| PAR1b promotes cell-cell adhesion and inhibits dishevelled-mediated transformation of Madin-Darby canine kidney cells | Q34886029 | ||
| An investigation of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers | Q35394836 | ||
| In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis | Q35594777 | ||
| Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase | Q35612267 | ||
| Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo | Q35720274 | ||
| AMP-activated protein kinase regulates the assembly of epithelial tight junctions | Q35768585 | ||
| LKB1 somatic mutations in sporadic tumors | Q35793276 | ||
| Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization | Q35990220 | ||
| LKB1 and AMPK maintain epithelial cell polarity under energetic stress | Q36119701 | ||
| Mammalian PAR-1 determines epithelial lumen polarity by organizing the microtubule cytoskeleton | Q36322073 | ||
| Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells | Q36573268 | ||
| Glucose metabolism and cancer | Q36625786 | ||
| Protein kinase Czeta-dependent LKB1 serine 428 phosphorylation increases LKB1 nucleus export and apoptosis in endothelial cells | Q36727225 | ||
| Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients | Q36785938 | ||
| The Par-1/MARK family of protein kinases: from polarity to metabolism | Q36919801 | ||
| Dialogue between LKB1 and AMPK: a hot topic at the cellular pole | Q36945343 | ||
| LKB1 and AMPK in cell polarity and division | Q37100013 | ||
| Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. | Q37250634 | ||
| Polarity proteins in migration and invasion | Q37333610 | ||
| Linking epithelial polarity and carcinogenesis by multitasking Helicobacter pylori virulence factor CagA. | Q37333631 | ||
| P433 | issue | 55 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6908-6919 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | LKB1; linking cell structure and tumor suppression | |
| P478 | volume | 27 |
| Q39392340 | A revisited concept: Contact inhibition of growth. From cell biology to malignancy |
| Q34390813 | A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo. |
| Q38977013 | A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway |
| Q39652265 | AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling |
| Q37429741 | AMP-activated protein kinase fortifies epithelial tight junctions during energetic stress via its effector GIV/Girdin |
| Q39463725 | AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. |
| Q92990038 | Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma |
| Q36283354 | Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis |
| Q39517661 | Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion. |
| Q37889961 | Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer |
| Q35740156 | Autophagy-based survival prognosis in human colorectal carcinoma |
| Q35858819 | Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice. |
| Q90358854 | Canine mammary tumor risk is associated with polymorphisms in RAD51 and STK11 genes |
| Q38168765 | Cellular polarity in aging: role of redox regulation and nutrition. |
| Q64099904 | Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development |
| Q49410803 | Colorectal polyposis and inherited colorectal cancer syndromes |
| Q47427450 | Construction of a prognostic prediction system for pancreatic ductal adenocarcinoma to investigate the key prognostic genes |
| Q36738017 | Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s |
| Q33821578 | Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action |
| Q37593372 | Coordinated cell motility is regulated by a combination of LKB1 farnesylation and kinase activity. |
| Q33820455 | Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer |
| Q28548411 | Deciphering Signaling Pathway Networks to Understand the Molecular Mechanisms of Metformin Action |
| Q36251554 | Defining the Molecular Nexus of Cancer, Type 2 Diabetes and Cardiovascular Disease |
| Q37969537 | Defining the molecular basis of tumor metabolism: a continuing challenge since Warburg's discovery |
| Q59355907 | Deregulation of methionine metabolism as determinant of progression and prognosis of hepatocellular carcinoma |
| Q36078996 | Differential control of Yorkie activity by LKB1/AMPK and the Hippo/Warts cascade in the central nervous system |
| Q58724065 | Emerging roles of long non-coding RNAs in tumor metabolism |
| Q52295693 | Energy addiction and lymphocyte differentiation: a new role for the liver kinase B1 kinase. |
| Q39763233 | Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer. |
| Q38717560 | Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis. |
| Q35014198 | Frontier of epilepsy research - mTOR signaling pathway |
| Q37855515 | Genetic and epigenetic changes in lung carcinoma and their clinical implications |
| Q37765099 | Genetics of biliary tract cancers and emerging targeted therapies |
| Q37215386 | Genome-wide RNAi screen reveals disease-associated genes that are common to Hedgehog and Wnt signaling. |
| Q33838679 | Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment. |
| Q33594309 | Glucose-dependent regulation of pregnane X receptor is modulated by AMP-activated protein kinase |
| Q22252312 | Hallmarks of Cancer: The Next Generation |
| Q26772317 | Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes |
| Q37281596 | Identification of RASAL1 as a major tumor suppressor gene in thyroid cancer |
| Q92702147 | IgG based immunome analyses of breast cancer patients reveal underlying signaling pathways |
| Q64114275 | Impact of liver kinase B1 on p53 and survivin and its correlation with prognosis in gastric cancer |
| Q29303134 | Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells |
| Q37896565 | Insights from model organisms on the functions of the tumor suppressor protein LKB1: zebrafish chips in. |
| Q46471150 | KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops |
| Q36905766 | LKB1 acts as a critical gatekeeper of ovarian primordial follicle pool |
| Q37383513 | LKB1 and AMP-activated protein kinase control of mTOR signalling and growth |
| Q64251353 | LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer |
| Q39026772 | LKB1 as a Tumor Suppressor in Uterine Cancer: Mouse Models and Translational Studies |
| Q34163651 | LKB1 destabilizes microtubules in myoblasts and contributes to myoblast differentiation |
| Q34155989 | LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells |
| Q36746175 | LKB1 kinase-dependent and -independent defects disrupt polarity and adhesion signaling to drive collagen remodeling during invasion |
| Q48569187 | LKB1 signaling in cephalic neural crest cells is essential for vertebrate head development |
| Q92060189 | LKB1 specifies neural crest cell fates through pyruvate-alanine cycling |
| Q38632879 | LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap |
| Q53744298 | Live kinase B1 maintains CD34+CD38- AML cell proliferation and self-renewal. |
| Q33849248 | Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy |
| Q37352985 | Lkb1/Stk11 regulation of mTOR signaling controls the transition of chondrocyte fates and suppresses skeletal tumor formation |
| Q28274325 | LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress |
| Q38934476 | Long non-coding RNAs in cancer metabolism |
| Q37616060 | Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer. |
| Q41179162 | Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis. |
| Q27853215 | Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38. |
| Q34430735 | Lovastatin induces multiple stress pathways including LKB1/AMPK activation that regulate its cytotoxic effects in squamous cell carcinoma cells |
| Q43141644 | Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients. |
| Q58596602 | Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming |
| Q39104277 | Mammalian target of rapamycin (mTOR): a central regulator of male fertility? |
| Q49612593 | Mechanisms, pathophysiological roles and methods for analyzing mitophagy - recent insights |
| Q34219451 | Metastasis suppression by adiponectin: LKB1 rises up to the challenge |
| Q34159241 | Metformin and cancer |
| Q36334079 | Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway |
| Q24603505 | MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells |
| Q26865743 | Mitophagy: mechanisms, pathophysiological roles, and analysis |
| Q82521439 | Molecular Genetics of Colorectal Cancer |
| Q35989684 | Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing |
| Q88801478 | Molecular Pathogenesis of Pancreatic Cancer |
| Q51546346 | Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1. |
| Q52594783 | Molecular cloning, polymorphism, and expression analysis of the LKB1/STK11 gene and its association with non-specific digestive disorder in rabbits. |
| Q33554797 | Multifaceted roles of adiponectin in cancer |
| Q33576271 | No association between promoter polymorphism of STK11 gene and lung cancer risk in the Korean population |
| Q61449692 | Oncogenic miR-744 promotes prostate cancer growth through direct targeting of LKB1 |
| Q93022998 | Pancreatic Cancer Early Detection and Interception in an Atypical Case of Peutz-Jeghers Syndrome |
| Q36910067 | Phosphorylation of serine 399 in LKB1 protein short form by protein kinase Cζ is required for its nucleocytoplasmic transport and consequent AMP-activated protein kinase (AMPK) activation |
| Q37544371 | Predominant regulators of tubulin monomer-polymer partitioning and their implication for cell polarization |
| Q41951381 | Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival |
| Q34878438 | Role of autophagy in liver physiology and pathophysiology |
| Q33425903 | Somatic LKB1 mutations promote cervical cancer progression |
| Q41677991 | Specific deletion of LKB1/Stk11 in the Müllerian duct mesenchyme drives hyperplasia of the periurethral stroma and tumorigenesis in male mice |
| Q35216960 | Stk11 (Lkb1) deletion in the osteoblast lineage leads to high bone turnover, increased trabecular bone density and cortical porosity |
| Q39190194 | Strategies to Target Glucose Metabolism in Tumor Microenvironment on Cancer by Flavonoids |
| Q34390606 | Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1. |
| Q37619860 | Targeting BET bromodomain proteins in solid tumors |
| Q27014838 | Targeting autophagy for the treatment of liver diseases |
| Q35004753 | The LKB1 tumor suppressor as a biomarker in mouse and human tissues |
| Q37350822 | The LKB1 tumor suppressor differentially affects anchorage independent growth of HPV positive cervical cancer cell lines |
| Q29617506 | The LKB1-AMPK pathway: metabolism and growth control in tumour suppression |
| Q37824021 | The LKB1/AMPK polarity pathway |
| Q34568200 | The Lkb1 metabolic sensor maintains haematopoietic stem cell survival |
| Q34490450 | The Pim protein kinases regulate energy metabolism and cell growth |
| Q41104247 | The effect of LKB1 on the PI3K/Akt pathway activation in association with PTEN and PIK3CA in HNC. |
| Q37333603 | The epithelial polarity program: machineries involved and their hijacking by cancer. |
| Q37831801 | The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling |
| Q39530750 | The modulatory effect of cell–cell contact on the tumourigenic potential of pre-malignant epithelial cells: a computational exploration |
| Q37715482 | The stress polarity pathway: AMPK 'GIV'-es protection against metabolic insults |
| Q37934215 | The tumor suppressor kinase LKB1: lessons from mouse models |
| Q28704108 | Transcriptome analysis of spermatogenically regressed, recrudescent and active phase testis of seasonally breeding wall lizards Hemidactylus flaviviridis |
| Q39689310 | Transcriptome profiling in response to adiponectin in human cancer-derived cells |
| Q35787307 | Tumor suppressor function of Liver kinase B1 (Lkb1) is linked to regulation of epithelial integrity |
| Q30495528 | Tumors as organs: complex tissues that interface with the entire organism |
| Q36326283 | Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma |
| Q30558691 | Unsupervised automated high throughput phenotyping of RNAi time-lapse movies |
| Q37333623 | Upsides and downsides to polarity and asymmetric cell division in leukemia. |
| Q37871529 | Viruses and the fuel sensor: the emerging link between AMPK and virus replication |
| Q42644515 | YAP/TAZ-mediated activation of serine metabolism and methylation regulation is critical for LKB1-deficient breast cancer progression |
| Q88435826 | Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival |
| Q40972751 | mTOR inhibitor treatment of pancreatic cancer in a patient With Peutz-Jeghers syndrome |
Search more.